Sven Karlsson, Platelet Biogenesis, Boston, MA
Startup, 2017 MBA Global Finals
Startup Success Story
Platelet Biogenesis Raises $10M Series A Eight Weeks After VCIC.
Platelet BioGenesis is a Harvard University spinout that is making human platelets from stem cells. We have developed and patented a microfluidic bioreactor, and shown that functional platelets can be generated from human pluripotent stem cell cultures. By removing the volunteer donor, we can make platelets that are cheaper, safer, and available on demand.Press Release